Position in ABVX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$13,326
New position
Shares Held
100
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#272
of 302 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aventura Private Wealth, LLC holds $606,898 across 23 Biotechnology names. ABVX ranks #13 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
267 | $166,485 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
10,000 | $87,550 | |
| 3 | OCS |
Oculis Holding AG
|
4,000 | $55,480 | |
| 4 | TECH |
BIO-TECHNE Corp
|
720 | $50,868 | |
| 5 | ARGX |
Argenx SE
|
50 | $46,388 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
1,990 | $33,670 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
62 | $33,290 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54 | $26,823 |
All Filings in ABVX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,326 | 100 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||